How do you deal with potential concerns or prejudices regarding the use of psychedelic substances in a therapeutic context?

Question

Prejudices regarding psychedelic substances often relate to the dangerous side of drug use. For instance, there is the notion that drugs are addictive; however, this is not the case with psilocybin. It is important that we properly inform everyone about psilocybin. Naturally, there are contraindications that we must certainly take into account, especially now. Because psychedelic therapy is relatively new after a long absence, every negative outcome is scrutinized. In conventional healthcare, there are many deaths due to medication misuse, and this is viewed as an acceptable risk. The entire psychedelic world still faces perfectionist ideas where nothing is allowed to go wrong.

We filter out many potential negative side effects by using an intake. In doing so, we pay attention to contraindications, which include:

Pregnancy
Schizophrenia
Bipolar disorder
Borderline disorder
Psychosis susceptibility (or history of psychosis)
Severe blood pressure/heart problems
Brain hemorrhages

Lithium
Heart medication
Blood pressure medication
Opioids (tramadol, morphine and codeine)
TCA (Amitryptiline, Nortriptyline, etc.)
MAO inhibitors (Phenelzine, Tranylcypromine, etc.)

View intake form

We also have protocols in place in case psilocybin sessions do not go as planned or if dangers arise. We therefore do everything possible to avoid causing negative experiences. We even attended the Trimbos Harm Reduction Congress to explain our efforts regarding harm reduction. In short, carefully minimizing the risk of negative outcomes from psilocybin therapy is key to addressing concerns and prejudices.

Triptherapie at Trimbos

Research · Accepted Answer

At Triptherapie, we understand that many questions, concerns, or even prejudices still exist regarding the therapeutic use of psychedelics. These substances carry a loaded history, partly due to their prohibited status in the past and unclear information from the media or culture. Therefore, we adopt an open, informative, and empathetic approach to address such concerns.

We always start with education and transparency. During the intake process It is discussed in detail what psychedelic therapy entails, what the role of the active substances is (such as psilocybin or MDMA analogues), and which scientific insights support its effectiveness. For example, we explain that psilocybin and MDMA therapy have now shown very positive results in multiple clinical studies for conditions including depression, PTSD, and anxiety disorders — naturally, always within a controlled, professional setting.

At the same time, we emphasize that psychedelic therapy is not suitable for everyone. Therefore, we carefully screen for medical and psychological contraindications. Only people who are suitable based on their health, motivation, and situation are admitted to a session. This ensures that safety and effectiveness always come first.

In addition, the accompaniment plays a crucial role in alleviating concerns. The sessions are not simply “trips,” but are profound therapeutic experiences under professional guidance. Clients are well-prepared, guided during the session, and helped with integration afterward. Many clients indicate that this provided confidence and peace, even if they were initially skeptical or anxious.

Finally, we also acknowledge the spiritual and emotional charge that psychedelics can evoke. Therefore, we adopt a holistic approach that includes mindset, nutrition, neurochemistry, and lifestyle. Concerns about loss of control, “bad trips,” or moral objections are taken seriously and discussed calmly—often leading to a reconsideration or deepening of understanding.

Do you have any concerns or doubts yourself about a truffle session or psilocybin sessionIf so, a no-obligation consultation or completing the intake form is a good first step. This way, we can explore together what suits you — without pressure, but with respect for your process.

Marcel · Answer

If we have ChatGPT answer the same question, this is the response:

The use of psychedelic substances in a therapeutic context can raise concerns and prejudices due to their history of abuse and stigmatization. Here are some ways to address potential concerns or prejudices:

Education: Provide factual and scientific information about psychedelic therapy. Emphasize the ongoing research into its effectiveness in the treatment of certain mental disorders. Sharing reliable information can help reduce misunderstandings.
Safety: Emphasize the safety of the approach. Research is conducted carefully using protocols and guidance by trained professionals to ensure participant safety. Stress that the use of psychedelics outside of controlled conditions can be risky.
Legal and Ethical Considerations: Emphasize that the use of psychedelic substances in a therapeutic context takes place within legal frameworks and ethical guidelines. Explain how this approach is supervised by professionals with the appropriate authorizations.
Individual Experiences: Share personal stories of people who have experienced positive results with psychedelic therapy. This can help to emphasize the human side of the approach and place emphasis on individual experiences.
Open Dialogue: Encourage open dialogue and answer questions. People may be hesitant due to a lack of understanding. An open conversation can help address specific concerns and provide clarity.
Focus on Therapeutic Goals: Emphasize the therapeutic goals of the treatment, such as exploring deep psychological patterns, promoting personal growth, and treating specific mental disorders. Highlighting the therapeutic value can help shift the focus.

It is important to acknowledge that psychedelic therapy is not suitable for everyone, and careful screening and assessment must always take place before this approach is considered. Building understanding and awareness can contribute to a more informed and open-minded attitude.

[Solved] How do you deal with potential concerns or prejudices regarding the use of psychedelic substances in a therapeutic context?